Think Investments LP Cassava Sciences Inc Transaction History

Think Investments LP

  • $477 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$17.22 - $38.47 $682,583 - $1.52 Million
-39,639 Reduced 26.2%
111,661 $1.88 Million
Q1 2022

May 16, 2022
SELL
$32.6 - $53.05 $1.63 Million - $2.65 Million
-50,000 Reduced 24.84%
151,300 $5.62 Million
Q4 2021

Feb 14, 2022
BUY
$36.77 - $90.91 $7.4 Million - $18.3 Million
201,300 New
201,300 $8.8 Million

Others Institutions Holding SAVA

# of Institutions
207
Shares Held
14M
Call Options Held
2.98M
Put Options Held
6.57M
View Full List

About CASSAVA SCIENCES INC

SAVA Quotes by TradingView
  • Ticker SAVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,097,900
  • Market Cap $94.2M
  • Description
  • Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...
More about SAVA
Track This Portfolio

Track Think Investments LP Portfolio

Follow Think Investments LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Think Investments LP, based on Form 13F filings with the SEC.

News

Stay updated on Think Investments LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email